INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← Blood pressure / Health Desk

Oats and blood pressure: a less settled result than the lipid findings

A large oat review found that blood-pressure interpretation depended on the comparison, with better trials still needed.

Whole-food ingredients prepared without added oil

Illustrative food image, not a photograph of the study intervention.

A broad review, not 74 pressure trials

The review included 74 randomized trials with 4,937 participants, and 59 trials contributed to its meta-analyses. It assessed cardiovascular risk markers across interventions using oats, oat beta-glucan-rich extracts, or avenanthramides. Participants predominantly had high cholesterol, obesity, or mild metabolic disturbances. Those totals describe the whole review, not a count of trials that each established a blood-pressure benefit. The authors explicitly considered dietary background and the nature of control groups. That structure is important for this question: a large collection of oat studies does not automatically mean equally extensive evidence for every measured endpoint, especially when the interventions themselves differed.

Llanaj E, Dejanovic GM, Valido E, Bano A et al.. European journal of nutrition, 2022. PMID 34977959 · DOI

Different controls, different findings

Against control arms without oats, the abstract reports improvements in several lipid, glucose, and body-size measures. Its statement about lower diastolic blood pressure appears instead in the comparison with heterogeneous interventions, such as wheat and rice. The abstract does not attach a numerical blood-pressure effect size to that statement. It would therefore be misleading to borrow one of the review's cholesterol numbers and present it as a pressure change, or to suggest that the no-oat comparisons proved the same pressure result. The comparator is part of the finding, and the abstract provides less quantitative detail for blood pressure than for several other outcomes.

Llanaj E, Dejanovic GM, Valido E, Bano A et al.. European journal of nutrition, 2022. PMID 34977959 · DOI

Bias concerns qualify the size of the evidence base

The majority of included trials, 81.1%, were rated as having some concerns for risk of bias. That percentage refers to the included randomized trials overall. It should not be recast as a blood-pressure-specific rating that the abstract does not give. The authors conclude that further high-quality trials are needed to establish the role of oat interventions in blood pressure, glucose homeostasis, and inflammatory markers. Their conclusion keeps the pressure question open despite the favorable diastolic statement in one comparator grouping. Counting studies is helpful, but the authors' assessment of their quality and the boundaries of each outcome are equally important.

Llanaj E, Dejanovic GM, Valido E, Bano A et al.. European journal of nutrition, 2022. PMID 34977959 · DOI

Disclosures and a bounded conclusion

The abstract's conflict-of-interest statement says that two authors were employees of Standard Process Inc. during manuscript development, writing, and submission. It also reports company support through a personal fee for another author and payment of the publication fee. Those disclosures should accompany a balanced account, without being treated as proof that the result is invalid. The review's own conclusion is already restrained: blood-pressure effects need higher-quality trials. Its interventions also included extracts and avenanthramides, not only ordinary oats. A whole-oat meal is therefore a food pairing, not a reconstruction of every intervention or a demonstrated treatment for hypertension.

Llanaj E, Dejanovic GM, Valido E, Bano A et al.. European journal of nutrition, 2022. PMID 34977959 · DOI